WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012115945) VIRAL INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/115945    International Application No.:    PCT/US2012/025905
Publication Date: 30.08.2012 International Filing Date: 21.02.2012
IPC:
A61K 31/4545 (2006.01)
Applicants: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM [US/US]; 201 W. 7th Street Austin, TX 78701 (US) (For All Designated States Except US).
MOUNT SINAI SCHOOL OF MEDICINE [US/US]; One Gustave L. Levy Place New York, NY 10029 (US) (For All Designated States Except US).
FONTOURA, Beatriz [BR/US]; (US) (For US Only).
GARCIA-SASTRE, Adolfo [ES/US]; (US) (For US Only).
VERSTEEG, Gijs [--/US]; (US) (For US Only).
ROTH, Michael [US/US]; (US) (For US Only).
SATTERLY, Neal [US/US]; (US) (For US Only)
Inventors: FONTOURA, Beatriz; (US).
GARCIA-SASTRE, Adolfo; (US).
VERSTEEG, Gijs; (US).
ROTH, Michael; (US).
SATTERLY, Neal; (US)
Agent: HIGHLANDER, Steven, L.; Fulbright & Jaworski L.L.P. 98 San Jacinto Boulevard Suite 1100 Austin, TX 78701 (US)
Priority Data:
61/444,962 21.02.2011 US
Title (EN) VIRAL INHIBITORS
(FR) INHIBITEURS VIRAUX
Abstract: front page image
(EN)The present invention generally relates to compounds to treat viral infections and methods of their use. In particular, compounds of the present invention inhibit the action of NSl protein, thereby mitigating viral infection and, in particular, influenza virus infection. Accordingly, NSl inhibitors and methods of treatment that employ such inhibitors are contemplated by the present invention.
(FR)Cette invention concerne, de manière générale, des composés destinés à traiter les infections virales et des méthodes pour les utiliser. En particulier, les composés selon l'invention inhibent l'action de la protéine NS1, atténuant ainsi l'infection virale et, en particulier, l'infection par le virus de la grippe. Par conséquent, cette invention concerne des inhibiteurs de NS1 et des méthodes de traitement faisant appel à ces inhibiteurs.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)